1Brigham and Women's Hospital, Boston, MA [email protected]
2Baylor College of Medicine, Houston, TX
Dr. Pfeffer reports receiving research grant support from Amgen, Celladon, Hamilton Health Sciences, Novartis, and Sanofi-Aventis; acting as a consultant to Aastrom Biosciences, Abbott Vascular, Amgen, Bristol-Myers Squibb, Cerenis Therapeutics, Concert Pharmaceuticals, FibroGen, Genzyme, GlaxoSmithKline, Medtronic, Merck, Novo Nordisk, Roche, Salix Pharmaceuticals, Sanderling Ventures, Servier, Teva Pharmaceuticals, and the University of Oxford; and being a coinventor on patents held by Brigham and Women's Hospital with Novartis for the use of inhibitors of the renin–angiotensin system in selected survivors of myocardial infarction. Dr. Pfeffer's shares of the licensing agreements are irrevocably transferred to charity. No other potential conflict of interest relevant to this letter was reported.
